Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Forecast 2025–2034: Where Businesses Should Invest Next
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market By 2029?
The artificial intelligence clinical trial protocol feasibility tool market has experienced substantial expansion in its size during recent years. Its valuation is forecasted to climb from $0.65 billion in 2024 to $0.83 billion in 2025, progressing at a compound annual growth rate (CAGR) of 27.5%. This historical upward trend can be attributed to factors such as the increasing intricacy of clinical trial protocols, the growing volume of clinical trial data, the escalating costs of conventional clinical trials, the wider adoption of digital health records, and a strengthened focus on patient-centric trials.
The artificial intelligence clinical trial protocol feasibility tool market size is anticipated to undergo significant growth over the next few years. It is projected to expand to $2.17 billion by 2029, achieving a compound annual growth rate (CAGR) of 27.1%. This projected expansion can be linked to an increasing demand for personalized medicine trials, the growing adoption of decentralized clinical trials, the expanding utilization of natural language processing, a stronger emphasis on patient diversity in trials, and the rising significance of real-time feasibility monitoring. Noteworthy trends for the forecast period encompass the development of adaptive algorithms to refine site selection, the integration of genomic data to facilitate precision trial protocols, innovations in automated trial cost and timeline estimation, the creation of tools to enhance patient diversity in clinical trials, and the incorporation of multi-source real-world evidence for accurate feasibility assessments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28142&type=smp
Which Drivers Are Shaping The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Industry’s Market Share?
The increasing focus on precision medicine is anticipated to accelerate the expansion of the artificial intelligence clinical trial protocol feasibility tool market moving forward. Precision medicine defines a customized healthcare strategy, leveraging a patient’s genetic makeup, environmental factors, and lifestyle to deliver more precise and efficacious therapies. This heightened emphasis on precision medicine stems from advancements in genomic sequencing and the identification of biomarkers, which facilitate accurate detection and the development of targeted treatments. Artificial intelligence clinical trial protocol feasibility tools augment precision medicine by facilitating data-driven trial designs, thereby making them perfectly suited for customizing treatments for distinct patient groups. These tools mitigate trial inefficiencies through their ability to forecast patient recruitment, project timelines, and assess risks, ultimately enhancing the accuracy and results of clinical research. As an illustration, in March 2024, Novotech, an Australia-based biotechnology company, reported that in 2023, 43% of the 217 FDA-approved oncology therapies were precision oncology treatments, with 78 incorporating DNA or NGS-detectable biomarkers. Consequently, the expanding focus on precision medicine is propelling the growth of the artificial intelligence clinical trial protocol feasibility tool market.
Which Key Segments Fueling The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?
The artificial intelligence clinical trial protocol feasibility tool market covered in this report is segmented as
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Protocol Design, Site Selection, Patient Recruitment, Risk Assessment, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Software: Predictive Analytics, Machine Learning, Natural Language Processing, Data Integration
2) By Services: Consulting, Implementation, Training And Support, Managed Services
What Trends Are Redefining The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Dynamics?
Major companies active in the artificial intelligence clinical trial protocol feasibility tool market are concentrating on developing innovative solutions, such as trial planning software powered by predictive analytics, to enhance the accuracy of protocol design and reduce delays in trials. Predictive analytics-based trial planning software is a solution that utilizes historical and real-time clinical trial data to forecast timelines, identify potential risks, and optimize study design for more streamlined and economical trials. For instance, in June 2024, Lokavant Inc., a US-based clinical intelligence company, unveiled Spectrum, the first artificial intelligence clinical trial feasibility solution aimed at optimizing trials from their strategic planning phase through mid-study re-forecasting. The platform features predictive analytics-based trial planning software that facilitates continuous, real-time feasibility analysis, timeline and cost prediction, and financial forecasting without requiring manual intervention. Spectrum delivers dynamic, real-time (re)forecasting by integrating live trial data, allowing study teams to monitor progress, explore alternative scenarios, and optimize enrollment outcomes. This solution also provides highly accurate predictions for timelines, costs, and operational risks, supporting faster, data-driven decision-making across the entire clinical trial lifecycle.
Which Key Players Are Driving Competition In The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?
Major companies operating in the artificial intelligence clinical trial protocol feasibility tool market are IQVIA Holdings Inc., SAS Institute Inc., Veeva Systems Inc., Tempus AI Inc., Cytel Inc., ArisGlobal LLC., Saama Technologies Inc., Norstella, ConcertAI, Komodo Health Inc., H1 Inc., TriNetX Inc., ObjectiveHealth LLC, Lokavant Inc., Inato Inc., Clinerion Ltd., Faro Health Inc., Lantern Pharma Inc., Ryght AI, and BEKHealth Corporation.
Download The Full Report For Exclusive Market Findings:
How Do Regional Market Performances Compare Within The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Industry?
North America was the largest region in the artificial intelligence clinical trial protocol feasibility tool market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence clinical trial protocol feasibility tool report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28142&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market 2025, By The Business Research Company
Artificial Intelligence Ai In Clinical Trials Global Market Report 2025
Ai Based Clinical Trial Solution Providers Global Market Report 2025
Ai In Clinical Trials Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
